Mutations in the Yeast Proteasome beta -Type Subunit Pre3 Uncover Position-dependent Effects on Proteasomal Peptidase Activity and in Vivo Function*

Roland GueckelDagger , Cordula Enenkel§, Dieter H. WolfDagger , and Wolfgang HiltDagger

From the Dagger  Institut für Biochemie, Universität Stuttgart, Pfaffenwaldring 55, 70569 Stuttgart and the § Institut für Biochemie, Charité der Humboldt Universität zu Berlin, Monbijoustrasse 2A, 10117 Berlin, Germany

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Proteasomes are highly complex proteases responsible for selective protein degradation in the eukaryotic cell. 26 S proteasomes consist of two regulatory 19 S cap complexes and the 20 S proteasome, which acts as the proteolytic core module. We isolated six mutants of the yeast Saccharomyces cerevisiae containing mutations in the 20 S proteasome beta -type subunit Pre3. Three mutations (pre3-2, pre3-3, and pre3-5) which reside at the active site cleft of the Pre3 subunit solely caused reduction of the proteasomal peptidylglutamyl peptide-hydrolyzing activity but did not lead to detectable defects in protein degradation nor to any other phenotype. However, the pre3-2 mutation strengthened phenotypes induced by other 20 S proteasomal mutations, indicating that the peptidylglutamyl peptide-hydrolyzing activity has to fulfill some rescue functions. The other three mutations (pre3-1, pre3-4, and pre3-6) are located at diverse sites of the Pre3 protein and caused multiple defects in proteasomal peptide cleaving activities. pre3-1 and pre3-6 mutants exhibited significant defects in proteasomal protein degradation; they accumulated ubiquitinated proteins and stabilized defined substrate proteins as, e.g. fructose-1,6-bisphosphatase. In addition, pre3-1 and pre3-6 mutant cells exhibited pleiotropic phenotypes as temperature sensitivity and cell cycle-related effects.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Proteasomes are large proteinase complexes operating in the cytoplasm and the nucleus of the eukaryotic cell. Two complexes are found: (i) the cylindrically shaped 20 S proteasome (molecular mass ~700 kDa) and (ii) the larger 26 S proteasome (molecular mass ~1700 kDa), which is composed of the 20 S proteasome as the proteolytic core and two additional 19 S cap complexes attached at both ends of the 20 S cylinder (1). Proteasomes are the major tool for selective protein degradation in the cytoplasm and nucleus of the eukaryotic cell (2-4).

26 S proteasomes degrade ubiquitinated proteins in an ATP-dependent reaction, whereas 20 S proteasomes are not able to do so. It is thought that the 19 S cap complexes of the 26 S proteasome, which consist of ATPases associated with various cellular activities and non-ATPase subunits are responsible for recognition, unfolding and transport of a substrate protein to the proteolytically active 20 S core. Using artificial peptide substrates, the 20 S proteasome exhibits at least three different proteolytic activities characterized by the type of amino acid where cleaving occurs: the chymotrypsin-like activity, the peptidylglutamyl peptide-hydrolyzing (PGPH)1 activity and the trypsin-like activity clipping at the C terminus of hydrophobic, acidic, and basic amino acids, respectively (5-8).

The cylindrically shaped 20 S proteasome consists of a stack of four rings, each containing seven subunits (4). In eukaryotes the outer rings are built up of seven different alpha -subunits, and the inner rings are composed of seven different beta -subunits, each. X-ray structure analysis of the ancestor 20 S proteasome from the prokaryote Thermoplasma acidophilum, which is composed of only one type of alpha - and beta -type subunit revealed the particle to be a hollow cylinder (9). The channel spanning the center of the complex is subdivided in three cavities. Both outer cavities are formed by the interfaces of the alpha  and beta  rings, whereas the central cavity, which contains the proteolytically active sites, is build up only from beta  rings (9). X-ray structure as well as mutational analysis uncovered the N-terminal threonine of the beta -type subunit to be essential for the proteolytic activity of the Thermoplasma proteasome (9, 10). Access to the active compartment is controlled by four narrow gates, and proteins have to be unfolded before degradation. This general design of the 20 S proteasome complex has recently been confirmed for eukaryotes by x-ray structure analysis of the yeast 20 S proteasome at a 2.4-Å resolution (11). This study in addition resolved the subunit arrangement of the eukaryotic 20 S proteasome, as well as structural details of individual subunits of the eukaryotic proteasome. X-ray structure in combination with lactacystin binding analysis determined the active sites of the yeast proteasome to locate at the beta -type subunits Pre2, Pre3, and Pup1 (11). Utilizing site directed mutagenesis of the essential N-terminal threonine residues of these subunits, the individual peptide cleaving activities could be assigned to one of these active subunits, each (12, 13); Pre2 confers the chymotrypsin-like activity, Pre3 the PGPH activity, and Pup1 the trypsin-like activity.

Proteasome-mediated degradation is linked to many different pathways of the cell. Proteasomes are implicated in stress response. They remove abnormal proteins generated by heat stress or exposure of cells to amino acid analogues (6, 14-16). Recent work demonstrated that proteasomes even degrade abnormal lumenal proteins of the endoplasmic reticulum, which have been transported to the cytoplasm prior to degradation (17, 18). Proteasome-dependent degradation of one or several defined substrate proteins has been found to constitute a significant step in various regulatory pathways of the cell. Proteasomes are involved in adaptation of metabolism by degrading enzymes as fructose-1,6-bisposphatase (19-21) or ornithine decarboxylase (22) as well as transcriptional regulators like Gcn4, which controls expression of metabolic enzymes (23). Proteasomes are also linked to cell differentiation as had been shown for the proteolytically unstable yeast MATalpha 2 transcriptional repressor protein (24, 25).

Most importantly, proteasomes play vital functions in the cell division cycle (for reviews, see Refs.26-28). In yeast, the central cdc2/Cdc28 kinase is cell cycle phase specifically activated by association with certain cyclin proteins. Such cyclin-dependent kinase complexes (CDKs) are inactivated by proteasome-mediated degradation of the respective cyclin proteins by this terminating distinct phases of the cell cycle (29, 30). Two different pathways act in recruiting cyclins for proteasomal destruction. G1 cyclins are tagged via Cdc34 complexed with Skp1, Cdc53, and the F-box protein Grr1 (SCF pathway) (for review, see Ref. 31). In contrast, the anaphase-promoting complex mediates B-type cyclin destruction in late mitosis (for review, see Refs. 28 and 31). Proteasomal destruction is also needed for removal of CDK inhibitor proteins as, e.g. the Sic1 protein (32). In contrast to cyclin destruction here proteolytic degradation results in activation of the respective CDK complex. Moreover, proteasomes degrade other cell cycle controlling proteins, which are not associated with cdc2/CDC28 kinase; anaphase-promoting complex mediated degradation of Pds1 (33), or Cut2 in Schizosaccharomyces pombe (34) and Ase1 (35) define essential transitions in mitosis.

In agreement with the fact that the beta -type subunits of the 20 S proteasome contain the proteolytically active sites previous screens for yeast cells with defects in 20 S proteasomal activities yielded only mutants harboring mutations in subunits of this type: Mutations residing in subunits Pre1 and Pre2 caused defects in chymotrypsin like activity (6, 14), whereas mutants harboring mutations in the proteasomal subunits Pre3 and Pre4 showed defective PGPH activity (15, 36). Interestingly mutants with impaired chymotrypsin like activity (pre1 and pre2) exhibited strong reduction in degradation of proteasomal substrates (6, 20, 24, 37, 38) whereas pre4-1 mutants which lack the PGPH activity did not show any decrease in protein degrading activity ((15) W. Hilt unpublished data).

Here, we present analysis of six pre3 mutant alleles; three mutations (pre3-2, pre3-3, pre3-5) residing in the substrate binding cleft of the Pre3 subunit exclusively caused defects in the PGPH activity of the complex. Interestingly, these mutations led to no detectable deficiency in proteasomal protein degradation. In addition, no other significant phenotype was found for these class of mutants. Three other mutations residing at distinct positions of the Pre3 subunit led to reduction of PGPH activity but also impaired other peptide cleaving activities. Two of these mutations, pre3-1 and pre3-6, led to strong defects in proteasomal proteolysis. These mutations in addition caused other significant phenotypes; mutants exhibited slow growth, sensitivity to elevated temperatures, impaired growth due to ectopical expression of cyclins, and other cell cycle-related effects.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials-- DNA restriction and modifying enzymes and the HindIII linker were obtained from Boehringer (Mannheim, Germany). Peptide substrates were from Bachem (Basel, Switzerland). AutoReadTM sequencing- and FluoroPrime labeling kit were from Amersham Pharmacia Biotech (Freiburg, Germany). 5-FOA was from Toronto Research Chem Inc. (North York, Canada).

Media-- Cells were grown either on YPD (1% yeast extract, 2% peptone, 2% glucose), or on minimal medium (0.67% Difco yeast nitrogen base without amino acids) containing 2% glucose or 2% ethanol as a carbon source and supplements (20 µg/ml uracil, 20 µg/ml histidine, 30 µg/ml leucine). Synthetic complete medium (CM) was prepared as outlined in Ref. 39. Selection for uracil auxotrophic cells was performed on mineral medium containing 50 µg/ml uracil and 0.1% w/v 5-fluoroorotic acid (5FOA). Sporulation medium contained 1% potassium acetate, 0.1% yeast extract, and 0.05% glucose. Radiolabeling was done in pulse medium (0.17% Difco yeast nitrogen base without amino acid and ammonium sulfate, 0.5% proline, 100 µM ammonium sulfate, 2% ethanol, and required supplements).

Manipulation of Microorganisms-- Growth, mating, sporulation, and tetrad dissection of yeast cells was performed using standard protocols (40, 41). Transformation of yeast cells with plasmids was done by the lithium acetate method (42). Temperature sensitivity was assayed by streaking cells on YPD agar plates at 37 °C and 30 °C for control. Growth and manipulation of Escherichia coli strains JM109 and DH5alpha was carried out following standard protocols (43). Growth medium for E. coli strains was LB medium (43) containing 50 mg/liter ampicillin if needed.

Isolation of Mutants-- To isolate mutants containing mutations in the PRE3 gene of the yeast 20 S proteasome strain FABYSD17c was mutagenized with ethylmethansulfonate (36) and thereafter screened for mutants defective in PGPH activity or trypsin-like activity. PGPH activity was measured using overlay assays with Cbz-Leu-Leu-Glu-beta NA as substrate as described in Ref. 15. Detection of the trypsin-like activity was performed with yeast colonies which were grown at 30 °C on YPD or selective medium to a minimum size of 3 mm and then replica-plated onto fresh agar plates (YPD or selective medium) covered with sterile filter dishes. The replica plates were incubated for 24 h at 30 °C. To permeabilize cells, filters were transferred to second filters which had been soaked with 1% toluol, 4% ethanol, 0.5 mM EDTA, 0.5 mM EGTA, 20 mM Tris/HCl, pH 9.0. After drying, filters were fixed to Petri dishes covered with 1% agar and overlaid with 10 ml of reagent mixture (1% agar, 45 °C, 20 mM Tris/HCl, pH 9.3, 100 µl of 250 mM Cbz-Ala-Arg-Arg-beta -naphthylamide) and incubated for at least 4 h at 48 °C. beta -Naphthylamide released from the peptide was detected by its UV fluorescence or by formation of a red dye by coupling with Fast Garnet GBC (10 ml of coupling mixture containing 0.2 M citrate, 4% Tween, pH 4.4, and 100 µl of Fast Garnet GBC (50 mg/ml in dimethyl sulfoxide)).

To confirm that mutations resided in the PRE3 gene, the mutant strains were crossed to the wild type strain YS18. Resulting diploids were sporulated. Tetrad analysis confirmed that mutants contained single gene mutations belonging to one complementation group. Mutations were proven to be allelic with PRE3 by complementing activity defects of pre3 segregants from these crosses with a YCp50-derived shuttle vector containing the PRE3 gene (36).

Preparation of Extracts, Enzyme Tests, and Immunological Detection of Ubiquitin-Protein Conjugates-- For testing proteasomal proteolytic activities, cells were grown in liquid YPD medium (1% yeast extract, 2% peptone, 2% glucose) into early stationary phase. Cell extracts were prepared by vortex mixing of 30% (v/v) cell suspensions in 50 mM Tris/HCl, pH 7.5, with equal volumes of washed glass beads for 3 min. The chymotrypsin-like activity and PGPH activity were measured in the supernatants using Cbz-Gly-Gly-Leu-4-nitroanilide or Cbz-Leu-Leu-Glu-beta NA as substrates as described (6, 15). The trypsin-like activity was measured in 100 mM Tris/HCl, pH 9.3, at 48 °C using Cbz-Ala-Arg-Arg-beta NA as substrate. For immunological detection of ubiquitin-protein conjugates, strains were grown in YPD medium into early stationary phase and divided in two aliquots, which were further incubated for 3 h at 37 °C or 30 °C. Preparation of extracts and immunoblotting using an ubiquitin-protein conjugate antibody was performed as described (15).

Pulse-Chase Analysis-- To investigate proteolytic degradation of fructose-1,6-bisphosphatase, immunoprecipitation and pulse-chase analysis were performed with the isogenic pre3 mutant strains YRG11, YRG12, YRG16, and the corresponding wild type strain WCG4a following methods described previously in Ref. 21. Western blot-based pulse-chase analysis was performed as followed: Cells were grown in glucose containing medium (YPD, CM) to A600 = 4-6. To induce fructose-1,6-bisphosphatase (FBPase) synthesis, cells were then transferred to glucose free ethanol medium (resulting A600 = 3) and incubated at 30 °C for 5 h. Thereafter, catabolite inactivation was induced by addition of glucose. Cells harvested at different chase times were broken, extracts were subjected to SDS gel electrophoresis, and FBPase contents were determined by immunoblotting.

Cloning of the pre3 Mutant Alleles-- Standard molecular biological methods were used (40). The pre3 mutant alleles were cloned by the gap repair method (44) or utilizing PCR amplification. For cloning by gap repair, the PRE3 3' flanking region (250-bp XmnI/NsiI fragment) and the 5' flanking region (248-bp NruI/EcoRI fragment) were joined by a EcoRI linker and cloned into the shuttle vector pRS316 (CEN6 URA3) (45). The resulting plasmid was linearized with EcoRI, and pre3 mutant strains were transformed. Uracil auxotrophic strains obtained were checked for the presence of repaired plasmids by plasmid rescue and restriction analysis. This approach was only successful in the case of strain C19 (pre3-3) allele. The other pre3 mutant alleles were therefore cloned by PCR amplification. The 1.4-kilobase pair NruI/SnaBI fragments containing the pre3 mutant loci were amplified using chromosomal DNA from strains C6, C13, FD80, and FD207 as templates and 5'-AAGGATCCCATACTTACCCTGCTCGCGA and 5'-AAAGGATCCGATACGTAGATACAGTCACCA as primers. Both primers contained a BamHI site at their 5' end, which was used for subcloning of the PCR fragments to the shuttle vector pRS315 (CEN6 LEU2) (45) yielding plasmids pRG21-pRG26.

Construction of Strains-- Standard yeast genetic and microbiological techniques (41) were used. Strains C6, C13, C19, FD80, and FD297 were generated by ethylmethansulfonate mutagenesis of strain FABYSD17C. A diploid pre3 knock-out mutant was generated as followed: A pRS316 based plasmid harboring a 1.4-kilobase NruI/SnaBI PRE3 fragment was gapped by HpaI digestion removing the complete PRE3 coding region and 6 bp from the 3'region as well as 47 bp from the 5'region. A 1.1-kilobase pair HindIII URA3 fragment excised from yEP24 was inserted using HindIII linker ligation. The deletion construct was excised as a BamHI/XhoI fragment. The diploid strain WCG4/4 was transformed with the linear fragment and uracil prototrophic strains were selected. To check correct deletion of PRE3 in strain YRG8, cells were sporulated and segregation of auxotrophic markers was determined. Spores derived from YRG8 tetrads showed a 2:0 segregation pattern (2 viable (ura3 PRE3); 2 inviable (ura3 pre3::URA3)). Correct integration was further confirmed by PCR. pre3 single mutant strains (YRG11-YRG16) isogenic with WCG4a were generated by a one-step gene replacement and checked for correct recombination by PCR. Strain YHI54/3211 is a spore clone derived from a cross of YRG12 against YHI29/1 (Table I).

Sequencing of Mutant Alleles-- The pre3 mutant alleles were sequenced by the dideoxy chain termination method using pRG21-pRG26 plasmids as templates. A double strand sequencing strategy was used as outlined in Ref. 36. Each allele was sequenced from the NruI site located in the PRE3 5' region up to 70 bp downstream from the PRE3 structural gene. Sequencing was performed on an A.L.F. automatic DNA-sequencer (Amersham Pharmacia Biotech) using the Auto-ReadTM sequencing kit and the FluoroPrimeTM labeling kit.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Isolation of pre3 Mutants-- A series of mutants containing mutations in the 20 S proteasome beta -type subunit Pre3 have been isolated. Three pre3 mutants (pre3-1 to pre3-3) had been found by screening ethylmethansulfonate-mutagenized yeast cells for colonies with reduced PGPH activity of the 20 S proteasome (36). An independent mutant screen searching for cells that were defective for the trypsin-like and/or the PGPH activity of the proteasome yielded two additional mutants allelic with PRE3, which were called pre3-4 and pre3-5. McCusker and Haber (46) had performed a screen for yeast mutants that showed resistance to a minimal concentration of cycloheximide and in addition exhibited temperature sensitivity. One of these mutants, crl21, uncovered to be allelic with PRE3 (16), which in this work is referred to as pre3-6.

Compared with wild type cells, all these pre3 mutants, pre3-1 through pre3-6, exhibit reduced PGPH activity when using Cbz-Leu-Leu-Glu-beta NA as a substrate. Three of these mutants, pre3-1, pre3-4, and pre3-6, additionally show defects in the trypsin-like activity of the 20 S proteasome. The pre3-6 mutant additionally is impaired in chymotrypsin like activity of the proteasome (data not shown; compare Fig. 1).

                              
View this table:
[in this window]
[in a new window]
 
Table I
List of strains


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   Proteasomal PGPH-, trypsin-like, and chymotrypsin-like activity in crude extracts of pre3 mutant strains. Data represent specific activities of wild type and pre3 mutant strains YRG11 (pre3-1), YRG12 (pre3-2), YRG13 (pre3-3), YRG14 (pre3-4), YRG15 (pre3-5), andYRG16 (pre3-6) in crude extracts against the peptide substrates Cbz-Leu-Leu-Glu-beta -naphthylamide (PGPH activity), Cbz-Ala-Arg-Arg-beta -naphthylamide (trypsin-like activity), and Cbz-Gly-Gly-Leu-4-nitroanilide (chymotrypsin-like activity). Values presented are means of three independent determinations.

Isolation of pre3 Mutant Alleles-- The pre3-3 allele was rescued by the gap repair method. pre3-3 mutant cells were transformed with a linear DNA fragment containing 3'and 5' homologous DNA sequences of the PRE3 promotor and terminator region separated by the backbone of the yeast shuttle vector pRS316 (URA3 CEN6). Plasmids repaired by homologous recombination were isolated from plasmid-dependent uracil prototrophic cells. Interestingly, in an attempt to rescue the other pre3 alleles, the gap repair method failed. We suggest this result to be due to reduced rates of homologous recombination found at regions adjacent to centromeres (49) as is the PRE3 locus. Therefore, the other pre3 alleles were isolated by PCR using primers which matched at 5' and 3' regions of the PRE3 locus yielding a 1.4-kilobase DNA fragment containing the sequence coding for the respective pre3 mutant allele, and flanking regions containing 341 base pairs of the PRE3 promotor and 327 base pairs of the terminator sequence. The fragments were subcloned to the yeast centromere vector pRS315 (LEU2 CEN6) yielding plasmids pRG21 through pRG26 and sequenced.

Generation of Isogenic pre3 Mutants-- The diploid yeast strain (yRG8) which contained a heterozygous chromosomal pre3Delta ::URA3 deletion was transformed with plasmids pRG21-pRG26 containing the pre3 mutant alleles. Cells were sporulated and tetrads dissected. Colonies derived from the spores were tested for uracil and leucine prototrophy by this, yielding haploid strains which contained the lethal pre3Delta ::URA3 deletion, but were viable due to the presence of the respective pre3 pRG plasmid. Proteasomal peptide cleaving activities of these plasmid-dependent pre3 mutants were tested and compared with proteolytic properties of the original pre3 mutant strains obtained by mutagenesis. No or only very slight deviations in the peptide cleaving activities were found (data not shown).

Isogenic mutants containing the different pre3 mutations on the chromosome were derived from the pRG21-26 plasmid-dependent mutant strains by a one step gene replacement technique: To enable growth of cells that, because of homologue recombination, had replaced the URA3 marker gene at the pre3Delta deletion locus with the respective plasmid encoded pre3 mutant sequence strains were grown without auxotrophic selection (YPD medium). Cells were then transferred to CM agar plates containing 5FOA by this selecting for uracil auxotrophic cells. Strains that have undergone correct recombination and integrated the respective pre3 mutant allele at its chromosomal locus should not further depend on the presence of the pRG plasmid. To enable mitotic loss of pRG plasmids (pre3 LEU2) cells were grown in rich medium. Cells were plated on YPD agar plates and thereafter screened for leucine auxotrophic colonies by this, yielding the isogenic pre3 mutant strains yRG11 to yRG16. Proteasomal peptide cleaving activities of these WCG4 isogenic pre3 mutant strains (YRG11-YRG16) were measured (Fig. 1). As compared with the original pre3 mutant strains obtained by mutagenesis, no significant deviations in peptide cleaving activities were found.

Sequences of the Different pre3 Alleles-- Sequences of the pre3 mutant alleles were determined (Fig. 2). pre3-1 contained one single amino exchange (G15D) located at the N-terminal region of the S2 beta -sheet. The pre3-1 mutation locates in close proximity to the active site cleft of the Pre3 subunit but also at a region responsible for Pre3-Pup1 beta -beta -contact. Three mutant alleles, pre3-2, pre3-3, and pre3-5, contained an exchange of glycine 47 (pre3-2 and pre3-5: G47D; pre3-3: G47S). pre3-5 in addition contained a mutation (V59A) located centrally to the H1 helix. Glycine 47 is entirely conserved in all beta -type subunits of the 20 S proteasome. It is located at a sharp bend between the C terminus of beta -sheet S4 and the N terminus of the H1 helix (11). This region and especially the adjacent residues Arg-45 and Ala-49 are involved in formation of the Pre3 substrate binding pocket (S1 pocket) (11). The pre3-4 mutant allele harbored a single amino acid exchange (G171D) residing centrally to the H4-S9 loop. This region is involved in Pre3-Pre3 as well as Pre3-Pre4 beta -ring-beta -ring interaction. Interestingly, for the pre3-6 mutant sequence a short deletion of 4 amino acids, Lys-85 through Glu-88, comprising the C terminus of the H2 helix was found. This region is in close proximity to the H2-S5 loop, which is part of the inner gates (the so-called beta -annulus) of the yeast 20 S proteasome (11).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 2.   Sequences of pre3 alleles. DNA and protein sequences of the wild type PRE3 gene and base pair and amino acid exchanges of pre3-1, pre3-2, pre3-3, pre3-4, pre3-5, and pre3-6 alleles. The protein sequence is numbered with respect to the mature Pre3 protein (N terminus of mature Pre3 indicated). Amino acid exchanges are printed in bold letters. The sequence deletion of pre3-6 is marked by hyphen. Consensi used for splicing are underlined. The secondary structure is shown according to Groll et al. (11).

pre3-1 and pre3-6 Are Deficient in Protein Degradation-- The series of pre3 mutants was tested for accumulation of ubiquitinated protein. This effect had been found as a typical phenotype of mutants defective in ubiquitin-proteasome-dependent protein degradation (6, 15, 16). Accumulation of ubiquitinated proteins significantly increased under certain stress conditions as heat stress or exposure of cells to amino acid analogues. Within the series of pre3 mutants, two strains YRG11 (pre3-1) and YRG16 (pre3-6) were found to accumulate ubiquitinated proteins at 30 °C and to stronger extent at 37 °C (Fig. 3A). In contrast as compared with wild type cells pre3-2 mutants (Fig. 3A) as well as pre3-3, pre3-4 and pre3-5 strains (data not shown) did not accumulate increased amounts of ubiquitinated proteins at both conditions.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3.   pre3-1 and pre3-6 mutant cells are defective in proteasomal protein degradation. A, pre3-1 and pre3-6 mutant cells accumulate enhanced amounts of ubiquitin conjugate proteins. Cells were grown to logarithmic phase in YPD-media at 30 °C. Thereafter, cells were heat-stressed at 37 °C for 3 h. Western blot analysis was performed to determine steady-state levels of ubiquitin conjugates in crude extracts of strains WCG4a (PRE3), YRG12 (pre3-2), YRG11 (pre3-1), and YRG16 (pre3-6) at 30 °C (left panel) and at 37 °C (right panel). B, beta -galactosidase activity in pre3 mutant strains expressing short-lived beta -gal N-end rule substrates. Data represent specific activities in crude extracts of wild type cells and mutant strains YRG11 (pre3-1), YRG12 (pre3-2), YRG13 (pre3-3), YRG14 (pre3-4), and YRG15 (pre3-5) expressing Ub-Pro-beta -gal and Arg-beta -gal. Values are compared with beta -galactosidase activity in wild type cells and represent means of three independent determinations. C, glucose-induced degradation of FBPase is reduced in pre3-1 and pre3-6 mutants. Pulse-chase analysis of FBPase degradation in wild type (WCG4a), YRG11(pre3-1), YRG12 (pre3-2), and YRG16 (pre3-6) yeast strains. Cells were pulse-labeled during derepression of FBPase in ethanol-containing medium and chased with the addition of glucose, followed by extraction, immunoprecipitation, and SDS-polyacrylamide gel electrophoresis. Rates of FBPase degradation were evaluated by phosphorimager-assisted quantification: FBPase half-life times were: wild type: tau  = 28 min; pre3-1: tau  = 70 min; pre3-2: tau  = 30 min; pre3-6: tau  = 131 min;

Additional evidence for a failure in proteasomal protein degradation of pre3-1 mutants came from measuring beta -galactosidase activity in cells expressing plasmid encoded proteolytically unstable versions of beta -galactosidase. Such beta -gal derivatives, (the so called N-end-rule substrates; Ref. 50) had been proven to be degraded via the ubiquitin-proteasome pathway (37, 38). As compared with the wild type strain, pre3-1 cells (YRG11) expressing plasmid-encoded short-lived R-beta -gal or Ub-P-beta -gal exhibited enhanced beta -galactosidase activity, indicating reduced turnover of this substrate protein in pre3-1 mutant cells (Fig. 3B). No enhanced activity levels were found in pre3-2, pre3-3, pre3-4, and pre3-5 mutant strains (Fig. 3B). Interestingly the pre3-6 mutant strain YRG16 did not tolerate R-beta -gal or Ub-P-gal encoding plasmids. When transformed with R-beta -gal or Ub-P-beta -gal containing plasmids strain YRG16 exhibited extremely poor transformation rates. The few transformants obtained in addition showed very slow growth and could not be used to determine beta -galactosidase activity in YRG16 cells.

A general defect in proteasomal proteolysis was substantiated in pre3-1 and pre3-6 mutants by measuring catabolite degradation of FBPase, a defined in vivo substrate of the ubiquitin-proteasome pathway (19-21). For both mutants, pre3-1 and pre3-6 strong proteolytic stabilization of FBPase was detected (Fig. 3C). In contrast, FBPase was degraded at wild type rates in pre3-2 mutant cells (Fig. 3C). In addition, utilizing Western blot-based pulse-chase experiments, no stabilization of FBPase was detected in pre3-3, pre3-4, and pre3-5 mutant cells (data not shown).

pre3-1 and pre3-6 Mutants Exhibit Growth Defects and Cell Cycle-related Defects-- Overexpression of certain cyclins acting in different phases of the cell cycle is not tolerated in pre3-1 and pre3-6 mutant cells. Ectopical expression of Gal promotor controlled plasmid encoded G1 cyclins CLN2 (Fig. 4A), CLN1 and CLN3 (data not shown) in strains YRG11 (pre3-1) and YRG16 (pre3-6) nearly completely abolished cell growth. Reduced growth was also found when overexpressing the S/G2 cyclin CLB5 (Fig. 4B) and to a minor extent the mitotic cyclin CLB2 in pre3-6 mutant cells (Fig. 4C). In pre3-1 mutant cells, CLB5 overexpression only slightly impaired cell growth (Fig. 4B), whereas no significant growth defect was observed when overexpressing CLB2 in pre3-1 cells (YRG11) (Fig. 4C). No such sensitivity to ectopically expressed cyclins were found in the other pre3 mutant strains: when overexpressing any cyclin in pre3-2, pre3-3, pre3-4, and pre3-5 strains, no additional reduction in cell growth as compared with wild type cells occurred (Fig. 4 and data not shown).


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 4.   pre3-2 and pre3-6 mutants are sensitive to overexpression of G1- and B-type cyclins. Growth of strainsWCG4a (PRE3) YRG11 (pre3-1), YRG12 (pre3-2), YRG13 (pre3-3), YRG14 (pre3-4), YRG15 (pre3-5), and YRG16 (pre3-6) containing plasmids encoding GAL1 promotor-driven CLN2 (plasmid pRD98; Ref. 51) (A) CLB5 (plasmid pWS1233; Ref. 29) (B), and CLB2 (plasmid pWS945; Ref. 29) (C) on CM agar medium containing glucose (left side, GAL1 repression) and CM medium containing galactose (right side, GAL1 induction).

pre3-2, pre3-3, pre3-4, and pre3-5 mutant cells grow at normal wild type rates at 30 °C (µ = 0.22 h-1) and 37 °C (Fig. 5A). Previously, we had found that a mutation residing in the Pre3 neighbor subunit Pre4 which also exclusively causes reduction of the proteasomal PGPH activity could enhance proteasomal defects induced by the pre1-1 mutation, which resides in another beta -type subunit and leads to defective chymotrypsin-like activity of the proteasome (15). An identical effect was found for pre3-2: This mutation when combined with the pre1-1 mutation significantly strengthened pre1-1 induced temperature sensitivity (Fig. 5B). In contrast to the other four pre3 mutant strains, pre3-1 and pre3-6 cells grow at reduced rates at 30 °C (pre3-1: µ = 0.11 h-1; pre3-6: µ = 0.08 h-1). As typically found for mutants defective in proteasomal degradation (6, 14-16, 52), both mutant strains, YRG11 (pre3-1) and YRG16 (pre3-6), show temperature sensitivity at 37 °C (Fig. 5A). When grown at 30 °C, YRG11 and YRG16 cells exhibited significantly reduced amounts of cells containing 1n DNA indicating premature entry into S-phase or prolonged transition through G2/M phase of the cell cycle (Fig. 6). After 2 h of incubation at 37 °C wild type and pre3-2 mutant cells show enhanced amounts of G1 cells (Fig. 6). This behavior is assigned to the transient G1 arrest that is known to occur after heat shock (53). As expected this arrest is resolved during further incubation (5 h). The same effect may also be responsible for increase of 1n DNA and decrease of 2n DNA amounts in pre3-1 and pre3-6 cells after 2 h of incubation at 37 °C. However, pre3-1 and pre3-6 cells, which stop growth at this elevated temperature, remain with this 1n/2n DNA ratio even after 5 h of incubation (Fig. 6). Data clearly show that pre3-1 and pre3-6 mutant cells do not arrest in a defined phase of the cell cycle and that temperature sensitivity of pre3-1 and pre3-6 mutants is a cell cycle-independent event.


View larger version (63K):
[in this window]
[in a new window]
 
Fig. 5.   Temperature sensitivity of pre3 single and pre3-2 pre1-1 double mutant strains. A, pre3-2 and pre3-6 mutants are temperature sensitive: Strain WCG4a (PRE3), YRG11 (pre3-1), YRG12 (pre3-2), YRG13 (pre3-3), YRG14 (pre3-4), YRG15 (pre3-5), and YRG16 (pre3-6) were streaked on YPD agar medium and incubated at 30 °C and 37 °C for 2 days. B, pre3-2 strengthens pre1-1-induced temperature sensitivity: Strains YRG12 (pre3-2), YHI29/1 (pre1-1), and YHI54/3211 (pre1-1, pre3-2), were streaked on YPD agar plates and incubated at 37 °C (top) or 30 °C (bottom) for 2 days.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 6.   Temperature sensitivity of pre3-1 and pre3-6 cells is cell cycle-independent. DNA contents of WCG4a (PRE3), YRG11 (pre3-1), YRG12 (pre3-2), and YRG16 (pre3-6) cells as seen by fluorescence-activated cell sorting analysis after 0, 2, and 5 h of incubation at 37 °C. pre3-1 and pre3-6 cells show retarded transition through G2/M phase. All strains show heat shock-induced increase of 1n DNA content after a 2-h shift to 37 °C. WCG4a and YRG12 DNA contents are balanced to normal ratio after 5 h of incubation at 37 °C. In contrast, YRG11 and YRG16 cells remain at the 2-h 1n/2n DNA ratio, even at 5 h of incubation, but do not arrest in a specific phase of the cell cycle.

Mutant strains YRG11 (pre3-1) and YRG12 (pre3-6) produce certain amounts of misshapen cells. Cells emerging a prolonged tubular bud or exhibiting dumbbell shape appear in YPD cultures of these strains (pre3-6: 4-6%; pre3-1: 2-3%; wild type and pre3-2 < 0.4% in 24-h YPD) (Fig. 7). Amounts are significantly enhanced after growth to stationary phase (pre3-6: 12-15% pre3-1: 4-8% after 3 days of growth in YPD).


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 7.   pre3-1 and pre3-6 mutant strains form abnormally shaped cells. Misshapen cells found in YPD cultures (72 h/30 °C) of strain YRG16 (pre3-6) were photographed with a Zeiss Axioskop. The bar represents 20 µm.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

We have isolated mutants carrying mutations in the 20 S proteasome subunit Pre3. Concerning their localization in the Pre3 structure as well as their influence on peptide cleaving activities of the 20 S proteasome, the isolated pre3 mutations can be subdivided in two groups. The first group of mutations (pre3-2, pre3-3, and pre3-5) residing near the active site cleft of the Pre3 subunit solely cause reduction of the PGPH activity of the 20 S proteasome. The second group of mutations (pre3-1, pre3-4, and pre3-6) locate at diverse sites of the Pre3 structure and lead to multiple defects in several peptide cleaving activities of the proteasome complex. Two of these mutations, pre3-1 and pre3-6, result in strongly impaired protein degradation via the proteasome pathway and cause other pleiotropic phenotypes. In contrast, pre3-4 mutants, which are only slightly reduced in trypsin-like and PGPH activity as well as all class I mutants, do not show any deficiency in proteasomal protein degradation or any other cellular phenotype.

X-ray structure and mutational analysis uncovered the Pre3 protein to carry an active site, which is thought to be responsible for the PGPH activity of the 20 S proteasome (11-13). This finding is confirmed by the fact that pre3-2, pre3-3, and pre3-5 mutations lead to sole reduction of the PGPH activity of the proteasome. All three mutants contain a mutation of glycine 47. This residue is completely conserved in all beta -type subunits analyzed so far and is part of the highly conserved so called GD-box spanning from Gly-47 to Asp-51. The strong conservation indicates that this sequence motif constitutes a structure essential for the function of the proteasome. X-ray structure data suggested that Gly-47 may essentially contribute to substrate cleavage. A fully occupied solvent molecule, which is thought to serve as the nucleophile attacking substrate molecules during hydrolysis, has been found in close vicinity to Gly-47. In addition, x-ray structure analysis of T. acidophilum (9) and S. cerevisiae (11) 20 S proteasomes treated with the inhibitor acetyl-Leu-Leu-norleucinal detected a hydrogen bond between Gly-47 and the inhibitor molecule. Moreover, Gly-47 locates to the center of a small loop between the S4 beta -sheet and the H1 alpha -helix (11). The adjacent residues Arg-45 and Ala-49 form the bottom of the binding cleft of the Pre3 subunit. Moreover, residue Arg-45 is thought to comprise the site responsible for specific binding of substrates containing an acidic amino acid at the cleavage site (11). Exchange of Gly-47 against larger amino acids may disturb coupling of the nucleophilic water molecule to the binding cleft. In addition, such new residue may reach into the binding cleft and sterically hinder substrate binding. One may alternatively imagine that exchange of Gly-47 against other residues may result in distortion of the sharp bend formed by Gly-47. By this, disarrangement of Arg-45 and Ala-49 may occur, which finally may lead to a strong deficiency in substrate binding. pre3-5 mutants in addition contained an exchange of valine 59 against alanine. However, the pre3-5 mutant showed the same phenotype as pre3-2 cells, which carry the identical exchange, G47D, indicating that the additional mutation of pre3-5 does not cause any effect on 20 S proteasome function.

Data clearly indicate that the pre3-2, pre3-3, and pre3-5 mutations lead to a specific effect which is limited to the Pre3 subunit of the 20 S proteasome. Interestingly, though almost completely lacking the proteasomal PGPH activity, no detectable defect on protein degradation nor any other additional cellular phenotype was found in these mutants. Identical results (loss of PGPH activity but no detectable defect in proteasomal protein degradation) had previously been obtained for pre3T1A mutants containing an exchange of the essential N-terminal threonine (13) as well as pre4-1 mutants lacking 15 amino acids at the C terminus of the Pre3 beta -ring neighbor Pre4 (15). It had been discussed that mutants, although completely deficient in cleaving the artificial peptide substrate Cbz-Leu-Leu-Glu-beta NA, may exhibit some residual activity for hydrolysis of peptide bonds within natural substrate proteins (15). This leakage model may now be excluded due to the fact that three structurally quite different mutations such as pre4-1, pre3T1A, and pre3G47D(S) lead to the same phenotypic effect. The data strongly indicate that loss of the PGPH activity does indeed not result in any deficiency in protein degradation via the proteasome. In case proteasomes lacking the PGPH activity were indeed fully active, the question arises why this activity has not been lost during evolution. Interestingly, pre4-1 (15) or pre3T1A (13) when combined with pre1-1 or pre2 mutations, which lead to defective chymotrypsin-like activity, significantly enhanced pre1-1- or pre2-induced defects. In agreement with these results, we now found that the pre3-2 mutation considerably strengthened pre1-1-induced temperature sensitivity. These data indicate that, when lacking one of the other activities, the PGPH activity may become important. Therefore, the necessity for the PGPH activity may rest in a redundancy function. Alternatively, it cannot be excluded that conditions may exist which require a proteasome with all proteolytic sites being active.

Similarly to pre3-2, pre3-3, and pre3-5 mutations, the pre3-4 mutation did not cause any defect in protein degradation nor any other phenotype. The pre3-4 mutation in addition to a defect in the PGPH activity caused reduction of the trypsin-like activity. However, both activities are reduced to only minor extents, and this may be the reason for the fact that pre3-4 does not lead to defective protein degradation. The mutation (G171D) resides in a region that is in close vicinity to the Pre3 and Pre4 subunits of the neighbor beta -ring. Even though pre3-4 more strongly influenced the trypsin-like activity, the mutation is not in close contact to the Pre3 beta -ring neighbor subunit Pup1 (11), which harbors the active site responsible for trypsin-like activity (13). As pre3-4 mutants showed normal chymotrypsin-like activity and in addition exhibited no other phenotype typically found in cells defective in proteasome function, this mutation does not seem to impair general formation of the 20 S proteasome complex. We assume that pre3-4 either influences the Pup1 subunit by a long distance effect or disturbs the local arrangement of the Pre3 Pre4 Pup1 subunit cluster

The pre3-1 mutation (G15D) locates to a region that is in close contact to the Pre3 active site cleft as well as the domain responsible for interaction of the Pre3 protein with its beta -ring neighbor Pup1. Therefore, reduction of both activities, the PGPH and the trypsin-like activity found in pre3-1 mutants, can most probably be explained by a pre3-1-induced structural alteration influencing the two active sites located within these subunits.

pre3-6 harbors a short deletion (Lys-85 to Glu-88) of the C-terminal part of the H2 helix. This region is directly connected to the H2-S5 loop, which forms the Pre3 part of the beta -ring gate (the so called beta -annulus; Ref. 11) located at the central channel of the 20 S proteasome. pre3-6 causes significant reductions of all three peptide cleaving activities. We therefore speculate that pre3-6 may lead to a severe alteration of the complete 20 S proteasomal beta -ring structure or may impair assembly of the 20 S complex.

Both mutations, pre3-1 and pre3-6, cause a deficiency in protein degradation as proven by stabilization of undefined ubiquitinated proteins as well as defined substrates of the proteasome pathway. In addition, these mutations resulted in pleiotropic phenotypes as temperature sensitivity and distinct cell cycle related effects. Although nearly identical, phenotypes seem to be slightly stronger expressed in pre3-6 mutants. We assume that both mutations lead to a general defect in proteasomal protein degradation. As indicated by the enhanced accumulation of ubiquitinated proteins at 37 °C, the temperature sensitivity of pre3-1 and pre3-6 cells can most probably be explained by insufficient removal of abnormal proteins generated under such heat stress conditions. In addition, in contrast to certain 19 S regulatory complex mutants (cim3/cim5) which, at restrictive temperature, stop growth in the G2/metaphase (54), temperature sensitivity of pre3-1 and pre3-6 cells was proven to be a cell cycle-independent event.

At permissive temperature, pre3-1 and pre3-6 mutants contained increased amounts of 2n DNA indicating a disturbed time course of cell cycle phases. This result may be explained by stabilization of certain cell cycle regulators. Cells expressing truncated proteolytically stabilized versions of G1 cyclins Cln3 or Cln2 (55, 56) or cells that due to a grr1 mutation show defective Cln degradation (57) prematurely enter S phase with a reduced G1 phase. In addition, progress through and exit from mitosis essentially requires proteasomal destruction of B-type cyclins (58, 59) and other mitotic regulators as Pds1 (33) or Ase1 (35). Therefore, enhanced amounts of 2n DNA containing cells detected in pre3-1 and pre3-6 mutant strains may be assigned to premature entry into a new cell cycle as well as delayed transition through mitosis. However, start into a new cell cycle also requires destruction of the CDK inhibitor Sic1 via the proteasome. Therefore, premature entry into S-phase may not occur in pre3-1 and pre3-6 cells. This view is supported by the fact that no significant decrease in cell size was observed for pre3-1 and pre3-6 mutants as is normally found for budding yeast cells showing accelerated transition through G1.

Ectopical expression of G1- and B-type cyclins in pre3-1 and pre3-6 mutant cells resulted in slightly to significantly reduced growth. In the case of B-type cyclin overexpression, the growth defect observed can most probably be attributed to impaired inactivation of B-type cyclin-dependent CDKs by this strengthening delayed exit from mitosis. Interestingly, stronger growth defects were found when overexpressing G1 cyclins in pre3-1 and pre3-6 mutant cells. However, no stringent necessity for G1 cyclin destruction could be detected so far (57). Therefore, sensitivity to ectopical expression found in pre3-1 and pre3-6 cells cannot be assigned to a defined process yet. Overexpression of Cln2 in wild type cells was found to result in hyperpolarization of cortical actin and secretion indicating that Cln1/2-dependent CDKs trigger polar bud growth (60). In agreement with these results, impaired degradation of Cln1/2 in grr1 mutant cells resulted in the formation of elongated cells (57). Therefore, appearance of misshapen cells with strongly elongated buds in cultures of pre3-1 and pre3-6 mutants may be explained by delayed degradation of Cln1/2 proteins.

    ACKNOWLEDGEMENTS

We thank C. Mann for friendly reception and support of R. G. during his stay in Gif-sur-Yvette. We also thank R. J. Deshaies, M. Kirschner, and W. Seufert for support with plasmids and M. Groll and R. Huber for providing structure data.

    FOOTNOTES

* This work was supported by a Program de Coopération Scientifique grant for scientific exchange from the Deutsche Akademische Austauschdienst, Bonn; by the Fonds der Chemischen Industrie, Frankfurt; and by the German Israeli Foundation for Scientific Research and Development, Jerusalem.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Institut für Biochemie, Universität Stuttgart, Pfaffenwaldring 55, 70569 Stuttgart, Germany. Tel.: 49-711-685-4388; Fax: 49-711-685-4392; E-mail: hilt{at}po.uni-stuttgart.de.

1 The abbreviations used are: PGPH, peptidylglutamyl peptide-hydrolyzing; Cbz, carbobenzoxyl; 5FOA, 5-fluoroorotic acid; beta -gal, beta -galactosidase; FBPase, fructose-1,6-bisphosphatase; CDK, cyclin-dependent kinase complex; bp, base pair(s); CM, complete medium; PCR, polymerase chain reaction; beta NA, beta -naphthylamide.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Peters, J. M. (1994) Trends Biochem. Sci. 19, 377-382[CrossRef][Medline] [Order article via Infotrieve]
  2. Hochstrasser, M. (1996) Annu. Rev. Genet. 30, 405-439[CrossRef][Medline] [Order article via Infotrieve]
  3. Coux, O., Tanaka, K., and Goldberg, A. L. (1996) Annu. Rev. Biochem. 65, 801-847[CrossRef][Medline] [Order article via Infotrieve]
  4. Hilt, W., and Wolf, D. H. (1996) Trends Biochem. Sci. 21, 96-102[CrossRef][Medline] [Order article via Infotrieve]
  5. Orlowski, M. (1990) Biochemistry 29, 10289-10297[Medline] [Order article via Infotrieve]
  6. Heinemeyer, W., Kleinschmidt, J. A., Saidowsky, J., Escher, C., and Wolf, D. H. (1991) EMBO J. 10, 555-562[Abstract]
  7. Orlowski, M., Cardozo, C., and Michaud, C. (1993) Biochemistry 32, 1563-1572[Medline] [Order article via Infotrieve]
  8. Rivett, A. J. (1989) J. Biol. Chem. 264, 12215-12219[Abstract/Free Full Text]
  9. Löwe, J., Stock, D., Jap, B., Zwick, P., Baumeister, W., and Huber, R. (1995) Science 268, 533-539[Medline] [Order article via Infotrieve]
  10. Seemüller, E., Lupas, A., Stock, D., Löwe, J., Huber, R., and Baumeister, W. (1995) Science 268, 579-582[Medline] [Order article via Infotrieve]
  11. Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., and Huber, R. (1997) Nature 386, 463-471[CrossRef][Medline] [Order article via Infotrieve]
  12. Arendt, C. S., and Hochstrasser, M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 7156-7161[Abstract/Free Full Text]
  13. Heinemeyer, W., Fischer, M., Krimmer, T., Stachon, U., and Wolf, D. H. (1997) J. Biol. Chem. 272, 25200-25209[Abstract/Free Full Text]
  14. Heinemeyer, W., Gruhler, A., Mohrle, V., Mahe, Y., and Wolf, D. H. (1993) J. Biol. Chem. 268, 5115-5120[Abstract/Free Full Text]
  15. Hilt, W., Enenkel, C., Gruhler, A., Singer, T., and Wolf, D. H. (1993) J. Biol. Chem. 268, 3479-3486[Abstract/Free Full Text]
  16. Gerlinger, U.-M., Gückel, R., Hoffmann, M., Wolf, D. H., and Hilt, W. (1997) Mol. Biol. Cell 8, 2487-2499[Abstract/Free Full Text]
  17. Hiller, M. M., Finger, A., Schweiger, M., and Wolf, D. H. (1996) Science 273, 1725-1728[Abstract/Free Full Text]
  18. Plemper, R. K., Bohmler, S., Bordallo, J., Sommer, T., and Wolf, D. H. (1997) Nature 388, 891-895[CrossRef][Medline] [Order article via Infotrieve]
  19. Schork, S. M., Bee, G., Thumm, M., and Wolf, D. H. (1994) Nature 369, 283-284[CrossRef][Medline] [Order article via Infotrieve]
  20. Schork, S. M., Bee, G., Thumm, M., and Wolf, D. H. (1994) FEBS Lett. 349, 270-274[CrossRef][Medline] [Order article via Infotrieve]
  21. Schork, S. M., Thumm, M., and Wolf, D. H. (1995) J. Biol. Chem. 270, 26446-26450[Abstract/Free Full Text]
  22. Murakami, Y., Matsufuji, S., Kameji, T., Hayashi, S., Igarashi, K., Tamura, T., Tanaka, K., and Ichihara, A. (1992) Nature 360, 597-599[CrossRef][Medline] [Order article via Infotrieve]
  23. Kornitzer, D., Raboy, B., Kulka, R. G., and Fink, G. R. (1994) EMBO J. 13, 6021-6030[Abstract]
  24. Richter-Ruoff, B., Wolf, D. H., and Hochstrasser, M. (1994) FEBS Lett. 354, 50-52[CrossRef][Medline] [Order article via Infotrieve]
  25. Chen, P., Johnson, P., Sommer, T., Jentsch, S., and Hochstrasser, M. (1993) Cell 74, 357-369[Medline] [Order article via Infotrieve]
  26. Deshaies, R. J. (1997) Curr. Opin. Genet. Dev. 7, 7-16[CrossRef][Medline] [Order article via Infotrieve]
  27. Deshaies, R. (1995) Trends Cell Biol. 5, 428-434[CrossRef]
  28. King, R. W., Deshaies, R. J., Peters, J.-M., and Kirschner, M. W. (1996) Science 274, 1652-1658[Abstract/Free Full Text]
  29. Seufert, W., Futcher, B., and Jentsch, S. (1995) Nature 373, 78-81[CrossRef][Medline] [Order article via Infotrieve]
  30. Yaglom, J., Linskens, M. H., Sadis, S., Rubin, D. M., Futcher, B., and Finley, D. (1995) Mol. Cell. Biol. 15, 731-741[Abstract]
  31. Hoyt, M. A. (1997) Cell 91, 149-151[Medline] [Order article via Infotrieve]
  32. Schwob, E., Bohm, T., Mendenhall, M. D., and Nasmyth, K. (1994) Cell 79, 233-244[Medline] [Order article via Infotrieve]
  33. Cohen-Fix, O., Peters, J. M., Kirschner, M. W., and Koshland, D. (1996) Genes Dev. 10, 3081-3093[Abstract]
  34. Funabiki, H., Yamano, H., Kumada, K., Nagao, K., Hunt, T., and Yanagida, M. (1996) Nature 381, 438-441[CrossRef][Medline] [Order article via Infotrieve]
  35. Juang, Y. L., Huang, J., Peters, J. M., McLaughlin, M. E., Tai, C. Y., and Pellman, D. (1997) Science 275, 1311-1314[Abstract/Free Full Text]
  36. Enenkel, C., Lehmann, H., Kipper, J., Guckel, R., Hilt, W., and Wolf, D. H. (1994) FEBS Lett 341, 193-6[CrossRef][Medline] [Order article via Infotrieve]
  37. Seufert, W., and Jentsch, S. (1992) EMBO J. 11, 3077-3080[Abstract]
  38. Richter-Ruoff, B., Heinemeyer, W., and Wolf, D. H. (1992) FEBS Lett. 302, 192-196[CrossRef][Medline] [Order article via Infotrieve]
  39. Sherman, F. (1991) Methods. Enzymol. 194, 3-21[Medline] [Order article via Infotrieve]
  40. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (1990) Current Protocols in Molecular Biology, Greene Publishing Association/Wiley, New York
  41. Guthrie, C., and Fink, G. R. (1991) Methods Enzymol. 194
  42. Gietz, D., St, J. A., Woods, R. A., and Schiestl, R. H. (1992) Nucleic Acids Res. 20, 1425[Medline] [Order article via Infotrieve]
  43. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  44. Rothstein, R. (1991) Methods Enzymol. 194, 281-301[Medline] [Order article via Infotrieve]
  45. Sikorski, R. S., and Hieter, P. (1989) Genetics 122, 19-27[Abstract/Free Full Text]
  46. McCusker, J. H., and Haber, J. E. (1988) Genetics 119, 303-15[Abstract/Free Full Text]
  47. Sengstag, C., and Hinnen, A. (1987) Nucleic Acids Res. 15, 233-246[Abstract]
  48. Wagner, J. C., and Wolf, D. H. (1992) Eur. J. Biochem. 203, 571-575[Abstract]
  49. Centola, M., and Carbon, J. (1994) Mol. Cell. Biol. 14, 1510-1519[Abstract]
  50. Bachmair, A., Finley, D., and Varshavsky, A. (1986) Science 234, 179-186[Medline] [Order article via Infotrieve]
  51. Deshaies, R. J., Chau, V., and Kirschner, M. (1995) EMBO J. 14, 303-312[Abstract]
  52. Friedman, H., and Snyder, M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2031-2035[Abstract]
  53. Johnston, G. C., and Singer, R. A. (1980) Mol. Gen. Genet. 178, 357-360[Medline] [Order article via Infotrieve]
  54. Ghislain, M., Udvardy, A., and Mann, C. (1993) Nature 366, 358-362[CrossRef][Medline] [Order article via Infotrieve]
  55. Cross, F. R., and Blake, C. M. (1993) Mol. Cell. Biol. 13, 3266-3271[Abstract]
  56. Tyers, M., Tokiwa, G., Nash, R., and Futcher, B. (1992) EMBO J. 11, 1773-1784[Abstract]
  57. Barral, Y., Jentsch, S., and Mann, C. (1995) Genes Dev. 9, 399-409[Abstract]
  58. Murray, A. (1995) Cell 81, 149-152[Medline] [Order article via Infotrieve]
  59. Murray, A. W., Solomon, M. J., and Kirschner, M. W. (1989) Nature 339, 280-286[CrossRef][Medline] [Order article via Infotrieve]
  60. Lew, D. J., and Reed, S. I. (1993) J. Cell Biol. 120, 1305-1320[Abstract]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.